Archive
68 stories
Enlarged prostate and prostate cancer share a name and a location, but they are not the same condition. Here is what 2025–2026 urology guidance says about BPH, screening, and when to worry.
Acid reflux affects roughly 20% of U.S. adults weekly. For many, PPIs are overprescribed and carry long-term risks. Here is the evidence-based path to relief without lifelong medication.
Prediabetes affects roughly 96 million U.S. adults, but GLP-1s are not the only answer. Here is what 2025-2026 evidence says about lifestyle, metformin, and when drugs fit.
TikTok pushes berberine as a natural GLP-1. Here is what 2025-2026 evidence says about the claim, the risks, and the reality.
A stubborn reading on medication panics patients. Here is what 2025-2026 evidence says about why pills lag and what actually lowers it.
The scale stops after early GLP-1 losses. Here is what 2025-2026 evidence says about plateaus, insulin, and what restarts progress.
Some women feel miserable starting hormone therapy. Here is what 2025-2026 evidence says about adjustment, red flags, and real relief.
Many people find magnesium triggers insomnia instead of calm. Here is what 2025-2026 evidence says about forms, timing, and what to do.
Hot homes threaten heat-sensitive meds. Here is what 2025-2026 evidence says about storage limits and protecting your prescriptions.
